1.
J Chemother
; 9(3): 238-40, 1997 Jun.
Article
in English
| MEDLINE
| ID: mdl-9210009
ABSTRACT
Two seriously neutropenic patients (a 23-year-old man with a promyelocytic acute myeloid leukemia [AML-M3] and a 77-year old male with an immature acute myeloid leukemia [AML-M1] diagnosis) with severe infections caused by Stenotrophomonas maltophilia were treated with aztreonam/clavulanic acid (2:1) combination. In the first patient the infection was caused by a multiresistant strain and in the second, by a strain with poor response to trimethoprim-sulfamethoxazole and other antimicrobial agents. After treatment with aztreonam/clavulanic acid both patients evolved favorably.
Subject(s)
Aztreonam/therapeutic use , Clavulanic Acids/therapeutic use , Drug Therapy, Combination/therapeutic use , Gram-Negative Bacterial Infections/drug therapy , Neutropenia/etiology , Xanthomonas/drug effects , Adult , Aged , Clavulanic Acid , Drug Resistance, Multiple , Gram-Negative Bacterial Infections/complications , Humans , Leukemia, Myeloid/complications , Male
2.
Rev Clin Esp
; 197 Suppl 1: 29-34, 1997 Apr.
Article
in Spanish
| MEDLINE
| ID: mdl-9297203
3.
Med Clin (Barc)
; 97(8): 316, 1991 Sep 14.
Article
in Spanish
| MEDLINE
| ID: mdl-1943310
